Sanchez crafts a tailored plan, selecting from therapies like ketamine infusions, hormone optimization, or IV nutrient therapy
Estudios de resultados cardiovasculares han demostrado reduccin de eventos mayores (MACE) con liraglutida (estudio LEADER), semaglutida subcutnea (SUSTAIN-6) y dulaglutida (REWIND) en pacientes con diabetes tipo 2 y factores de riesgo o enfermedad cardiovascular establecida
Oversight in 2025 shows that the agency is watching the GLP-1 space (diabetes, obesity, weight loss drugs) particularly closely, compounded versions or unverified imports will face tough regulatory headwinds
Again, there is no strong evidence linking Morosil with increased GLP-1 levels, remarks Dr Tayal. The final verdict Dr Tayal concludes that Kourtneys newly launched supplement may help in reducing food cravings and may aid in weight loss, but there is no substantial evidence that it will help increase GLP-1 hormone
But the agencys plan could also make it more difficult for legitimate compounders to produce the drugs